Vitamin A and the nursing mother-infant DYAD: Evidence for intervention

Rebecca J. Stoltzfus, Jean Hawes Humphrey

Research output: Contribution to journalArticle

Abstract

From the evidence at hand, interventions to reduce vitamin A deficiency in the breastfeeding mother and baby are likely to confer several health benefits. These include reduced puerperal morbidity, night blindness, and mortality in the mother, and reduced morbidity and mortality in the baby beginning around 6 months of age. Additional evidence is still needed to increase our confidence in these inferences, and to clarify the best interventions for achieving these outcomes. Current evidence about the effects of improved vitamin A status on early infant morbidity or mortality is mixed. There is accumulating evidence against the hypothesis that maternal vitamin A supplementation during pregnancy will reduce mother-to-child HIV transmission. There is so far no evidence about whether improved infant vitamin A status can prevent mother-to-child HIV transmission. In sum, the probable benefits of improving the vitamin A status of the breastfeeding mother and her baby are substantial, but to achieve these benefits, more aggressive interventions will be needed.

Original languageEnglish (US)
Pages (from-to)39-47
Number of pages9
JournalAdvances in Experimental Medicine and Biology
Volume503
StatePublished - 2002

Fingerprint

Nursing
Vitamin A
Mothers
Breast Feeding
Morbidity
Mortality
HIV
Night Blindness
Vitamin A Deficiency
Insurance Benefits
Health
Hand
Pregnancy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Vitamin A and the nursing mother-infant DYAD : Evidence for intervention. / Stoltzfus, Rebecca J.; Humphrey, Jean Hawes.

In: Advances in Experimental Medicine and Biology, Vol. 503, 2002, p. 39-47.

Research output: Contribution to journalArticle

@article{f0b7c7eb9cd148cab14b7b575f6916d2,
title = "Vitamin A and the nursing mother-infant DYAD: Evidence for intervention",
abstract = "From the evidence at hand, interventions to reduce vitamin A deficiency in the breastfeeding mother and baby are likely to confer several health benefits. These include reduced puerperal morbidity, night blindness, and mortality in the mother, and reduced morbidity and mortality in the baby beginning around 6 months of age. Additional evidence is still needed to increase our confidence in these inferences, and to clarify the best interventions for achieving these outcomes. Current evidence about the effects of improved vitamin A status on early infant morbidity or mortality is mixed. There is accumulating evidence against the hypothesis that maternal vitamin A supplementation during pregnancy will reduce mother-to-child HIV transmission. There is so far no evidence about whether improved infant vitamin A status can prevent mother-to-child HIV transmission. In sum, the probable benefits of improving the vitamin A status of the breastfeeding mother and her baby are substantial, but to achieve these benefits, more aggressive interventions will be needed.",
author = "Stoltzfus, {Rebecca J.} and Humphrey, {Jean Hawes}",
year = "2002",
language = "English (US)",
volume = "503",
pages = "39--47",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Vitamin A and the nursing mother-infant DYAD

T2 - Evidence for intervention

AU - Stoltzfus, Rebecca J.

AU - Humphrey, Jean Hawes

PY - 2002

Y1 - 2002

N2 - From the evidence at hand, interventions to reduce vitamin A deficiency in the breastfeeding mother and baby are likely to confer several health benefits. These include reduced puerperal morbidity, night blindness, and mortality in the mother, and reduced morbidity and mortality in the baby beginning around 6 months of age. Additional evidence is still needed to increase our confidence in these inferences, and to clarify the best interventions for achieving these outcomes. Current evidence about the effects of improved vitamin A status on early infant morbidity or mortality is mixed. There is accumulating evidence against the hypothesis that maternal vitamin A supplementation during pregnancy will reduce mother-to-child HIV transmission. There is so far no evidence about whether improved infant vitamin A status can prevent mother-to-child HIV transmission. In sum, the probable benefits of improving the vitamin A status of the breastfeeding mother and her baby are substantial, but to achieve these benefits, more aggressive interventions will be needed.

AB - From the evidence at hand, interventions to reduce vitamin A deficiency in the breastfeeding mother and baby are likely to confer several health benefits. These include reduced puerperal morbidity, night blindness, and mortality in the mother, and reduced morbidity and mortality in the baby beginning around 6 months of age. Additional evidence is still needed to increase our confidence in these inferences, and to clarify the best interventions for achieving these outcomes. Current evidence about the effects of improved vitamin A status on early infant morbidity or mortality is mixed. There is accumulating evidence against the hypothesis that maternal vitamin A supplementation during pregnancy will reduce mother-to-child HIV transmission. There is so far no evidence about whether improved infant vitamin A status can prevent mother-to-child HIV transmission. In sum, the probable benefits of improving the vitamin A status of the breastfeeding mother and her baby are substantial, but to achieve these benefits, more aggressive interventions will be needed.

UR - http://www.scopus.com/inward/record.url?scp=0035991822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035991822&partnerID=8YFLogxK

M3 - Article

C2 - 12026026

AN - SCOPUS:0035991822

VL - 503

SP - 39

EP - 47

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -